Author:
Häβler Frank,Thome Johannes,Reis Olaf
Publisher
Springer Science and Business Media LLC
Subject
Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology
Reference61 articles.
1. Advokat CD, Mayville EA, Matson JL (2000) Side effect profiles of atypical antipsychotics, typical antipsychotics, or no psychotropic medications in persons with mental retardation. Res Dev Disabil 21:75–84
2. Alper K, Schwartz KA, Kolts RL, Khan A (2007) Seizure incidence in psychopharmacological clinical trials: an analysis of FDA summary basis of approval reports. Biol Psychiatry 62:345–354
3. Aman MG (1983) Psychoactive drugs in mental retardation. In: Matson JL, Andrasik F (eds) Treatment issues and innovations in mental retardation. Plenum Press, New York, pp 455–513
4. Aman MG, Singh NN (1988) Patterns of drug use: methodological considerations, measurement techniques, and future trends. In: Aman MG, Singh NN (eds) Psychopharmacology of the developmental disabilities. Springer, New York, pp 1–28
5. Aman MG, Buican B, Arnold LE (2003) Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. J Child Adolesc Psychopharmacol 13:29–40
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献